Liao, K. P., Rist, P., Giles, J., Santacroce, L., Connelly, M. A., Glynn, R. J., Ridker, P., Tawakol, A., Bathon, J., & Solomon, D. H. (2024). Impact of RA treatment strategies on lipids and vascular inflammation in rheumatoid arthritis: a secondary analysis of the TARGET randomized active comparator trial. Arthritis Research & Therapy, 26(1). https://doi.org/10.1186/s13075-024-03352-3

Baker, J. F., ODell, J. R., England, B. R., Giles, J. T., Newcomb, J. A., George, M. D., Thiele, G., Moreland, L., Bridges, S. L., Curtis, J. R., & Mikuls, T. R. (2024). Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis. Annals of the Rheumatic Diseases, 83(4), 429–436. https://doi.org/10.1136/ard-2023-225014

Di Matteo, A., Bathon, J. M., & Emery, P. (2023). Rheumatoid arthritis. The Lancet, 402(10416), 2019–2033. https://doi.org/10.1016/s0140-6736(23)01525-8

Bass, A. R., Chakravarty, E., Akl, E. A., Bingham, C. O., Calabrese, L., Cappelli, L. C., Johnson, S. R., Imundo, L. F., Winthrop, K. L., Arasaratnam, R. J., Baden, L. R., Berard, R., Bridges, S. L., Cheah, J. T. L., Curtis, J. R., Ferguson, P. J., Hakkarinen, I., Onel, K. B., Schultz, G., … Reston, J. (2023). 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis & Rheumatology, 75(3), 333–348. Portico. https://doi.org/10.1002/art.42386

Solomon, D. H., Giles, J. T., Liao, K. P., Ridker, P. M., Rist, P. M., Glynn, R. J., Broderick, R., Lu, F., Murray, M. T., Vanni, K., Santacroce, L. M., Abohashem, S., Robson, P. M., Fayad, Z., Mani, V., Tawakol, A., & Bathon, J. (2022). Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 82(3), 324–330. https://doi.org/10.1136/ard-2022-223302

Bass, A. R., Chakravarty, E., Akl, E. A., Bingham, C. O., Calabrese, L., Cappelli, L. C., Johnson, S. R., Imundo, L. F., Winthrop, K. L., Arasaratnam, R. J., Baden, L. R., Berard, R., Bridges, S. L., Cheah, J. T. L., Curtis, J. R., Ferguson, P. J., Hakkarinen, I., Onel, K. B., Schultz, G., … Reston, J. (2023). 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Care & Research, 75(3), 449–464. Portico. https://doi.org/10.1002/acr.25045

Charles-Schoeman, C., Buch, M. H., Dougados, M., Bhatt, D. L., Giles, J. T., Ytterberg, S. R., Koch, G. G., Vranic, I., Wu, J., Wang, C., Kwok, K., Menon, S., Rivas, J. L., Yndestad, A., Connell, C. A., & Szekanecz, Z. (2022). Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance. Annals of the Rheumatic Diseases, 82(1), 119–129. https://doi.org/10.1136/ard-2022-222259

Smolen, J. S., Landewé, R. B. M., Bergstra, S. A., Kerschbaumer, A., Sepriano, A., Aletaha, D., Caporali, R., Edwards, C. J., Hyrich, K. L., Pope, J. E., de Souza, S., Stamm, T. A., Takeuchi, T., Verschueren, P., Winthrop, K. L., Balsa, A., Bathon, J. M., Buch, M. H., Burmester, G. R., … van der Heijde, D. (2022). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the Rheumatic Diseases, 82(1), 3–18. https://doi.org/10.1136/ard-2022-223356

Almeida-Brasil, C. C., Hanly, J. G., Urowitz, M., Clarke, A. E., Ruiz-Irastorza, G., Gordon, C., Ramsey-Goldman, R., Petri, M. A., Ginzler, E. M., Wallace, D. J., Bae, S.-C., Romero-Diaz, J., Dooley, M.-A., Peschken, C., Isenberg, D., Rahman, A., Manzi, S., Jacobsen, S., Lim, S. S., … Bernatsky, S. (2022). Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine. Lupus Science & Medicine, 9(1), e000789. https://doi.org/10.1136/lupus-2022-000789

White, I. R., Kleinstein, S. E., Praet, C., Chamberlain, C., McHale, D., Maia, J. M., Xie, P., Goldstein, D. B., Urban, T. J., & Shea, P. R. (2022). A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population. PLOS ONE, 17(4), e0261165. https://doi.org/10.1371/journal.pone.0261165

Wang, R., Dasgupta, A., & Ward, M. M. (2022). Predicting Probability of Response to Tumor Necrosis Factor Inhibitors for Individual Patients With Ankylosing Spondylitis. JAMA Network Open, 5(3), e222312. https://doi.org/10.1001/jamanetworkopen.2022.2312

Almeida-Brasil, C. C., Hanly, J. G., Urowitz, M., Clarke, A. E., Ruiz-Irastorza, G., Gordon, C., Ramsey-Goldman, R., Petri, M., Ginzler, E. M., Wallace, D. J., Bae, S.-C., Romero-Diaz, J., Dooley, M. A., Peschken, C., Isenberg, D., Rahman, A., Manzi, S., Jacobsen, S., Lim, S., … Bernatsky, S. (2022). Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Annals of the Rheumatic Diseases, 81(3), 370–378. https://doi.org/10.1136/annrheumdis-2021-221295

Griffin, J. M., Baughan, E., Rosenblum, H., Clerkin, K. J., Fried, J. A., Raikhelkar, J., Uriel, N., Brannagan, T. H., Takeda, K., Grodin, J. L., Marboe, C., Maurer, M. S., & Farr, M. A. (2022). Surveillance for disease progression of transthyretin amyloidosis after heart transplantation in the era of novel disease modifying therapies. The Journal of Heart and Lung Transplantation, 41(2), 199–207. https://doi.org/10.1016/j.healun.2021.10.007